DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,728,560 | -26.1% | 160,131 | -28.5% | 0.93% | -22.9% |
| Q2 2023 | $53,773,436 | -5.4% | 224,055 | -0.6% | 1.21% | -11.4% |
| Q1 2023 | $56,817,448 | -4.4% | 225,430 | +0.6% | 1.36% | -8.0% |
| Q4 2022 | $59,458,801 | +9.4% | 224,018 | +6.5% | 1.48% | -0.7% |
| Q3 2022 | $54,341,000 | +7.5% | 210,387 | +5.6% | 1.49% | +15.2% |
| Q2 2022 | $50,529,000 | -12.4% | 199,308 | +1.3% | 1.30% | -1.4% |
| Q1 2022 | $57,689,000 | -10.7% | 196,670 | +0.1% | 1.31% | -6.5% |
| Q4 2021 | $64,632,000 | +9.0% | 196,445 | +0.8% | 1.40% | -2.7% |
| Q3 2021 | $59,320,000 | +12.2% | 194,849 | -1.1% | 1.44% | +12.0% |
| Q2 2021 | $52,871,000 | +17.4% | 197,016 | -1.5% | 1.29% | +7.5% |
| Q1 2021 | $45,036,000 | +1.2% | 200,088 | -0.1% | 1.20% | -2.5% |
| Q4 2020 | $44,498,000 | +3.0% | 200,315 | -0.1% | 1.23% | -7.5% |
| Q3 2020 | $43,188,000 | +18.8% | 200,568 | -2.5% | 1.33% | +9.1% |
| Q2 2020 | $36,360,000 | +23.6% | 205,620 | -3.3% | 1.22% | +5.4% |
| Q1 2020 | $29,427,000 | -10.6% | 212,610 | -0.8% | 1.16% | +9.4% |
| Q4 2019 | $32,908,000 | +0.3% | 214,412 | -5.6% | 1.06% | -8.5% |
| Q3 2019 | $32,796,000 | +3.4% | 227,075 | +2.3% | 1.16% | +1.5% |
| Q2 2019 | $31,717,000 | +9.8% | 221,920 | +1.5% | 1.14% | +3.1% |
| Q1 2019 | $28,877,000 | +4878.8% | 218,736 | +3787.3% | 1.10% | -35.1% |
| Q4 2018 | $580,000 | -96.8% | 5,627 | -96.7% | 1.70% | +107.9% |
| Q3 2018 | $18,270,000 | -19.6% | 168,134 | -27.0% | 0.82% | -15.8% |
| Q2 2018 | $22,723,000 | +5.6% | 230,271 | +4.8% | 0.97% | +9.3% |
| Q1 2018 | $21,517,000 | +8.7% | 219,767 | +3.0% | 0.89% | +11.6% |
| Q4 2017 | $19,800,000 | +11.0% | 213,314 | +2.6% | 0.80% | +3.8% |
| Q3 2017 | $17,840,000 | +5.6% | 207,966 | +3.9% | 0.77% | +0.8% |
| Q2 2017 | $16,887,000 | +7.3% | 200,107 | +8.7% | 0.76% | +6.0% |
| Q1 2017 | $15,742,000 | +9.9% | 184,049 | +0.0% | 0.72% | +5.3% |
| Q4 2016 | $14,324,000 | -3.5% | 184,012 | -2.8% | 0.68% | -5.8% |
| Q3 2016 | $14,846,000 | -23.8% | 189,378 | -1.9% | 0.72% | -25.6% |
| Q2 2016 | $19,495,000 | +11.1% | 193,017 | +4.3% | 0.97% | +6.6% |
| Q1 2016 | $17,554,000 | +8.2% | 185,052 | +5.9% | 0.91% | +9.5% |
| Q4 2015 | $16,227,000 | +23.9% | 174,717 | +13.6% | 0.83% | +17.5% |
| Q3 2015 | $13,102,000 | -11.2% | 153,759 | -10.8% | 0.71% | -3.3% |
| Q2 2015 | $14,755,000 | +7.8% | 172,391 | +6.9% | 0.73% | +7.3% |
| Q1 2015 | $13,688,000 | -3.1% | 161,226 | -2.2% | 0.68% | -2.1% |
| Q4 2014 | $14,124,000 | +13.5% | 164,795 | +0.6% | 0.70% | +9.6% |
| Q3 2014 | $12,448,000 | +4.6% | 163,833 | +8.4% | 0.64% | +4.4% |
| Q2 2014 | $11,896,000 | +24.6% | 151,099 | +18.7% | 0.61% | +21.0% |
| Q1 2014 | $9,550,000 | +0.6% | 127,325 | +3.5% | 0.50% | -0.8% |
| Q4 2013 | $9,497,000 | +780.2% | 123,025 | +690.1% | 0.51% | +707.9% |
| Q3 2013 | $1,079,000 | – | 15,570 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |